Immunocompromised Host

Publication Title: 
Nihon Rinsho. Japanese Journal of Clinical Medicine

Medicinal herbs, Geum japonicum, Syzygium aromaticum, Terminalia chebula, and Rhus javanica, with anti-herpes simplex virus therapeutic activity, inhibited replication of human cytomegalovirus(CMV) and murine CMV(MCMV) in vitro. These anti-CMV activities were examined in an MCMV infection model using immunosuppressed mice. Geum japonicum, Syzygium aromaticum, and Terminalia chebula significantly suppressed MCMV yields in lungs of treated mice compared with water treatment.

Shiraki, K.
Yukawa, T.
Kurokawa, M.
Kageyama, S.
Publication Title: 
Voprosy Onkologii

The study group included 21 patients with malignant melanoma stage II-IV, aged 25-67, and 25 patients, aged 28-68, (control) with stomach tumors stage I-IV. All patients received individually-tailored hypnosis. Our newly-developed methods used batteries of suggestive images to deal with non-psychotic disorders and to map out strategies to support immunocompromised patients. In group 1, suggestion stimulated the "devouring" effect of the "patroling" cells.

Bukhtoiarov, O. V.
Kozhevnikov, V. S.
Samarin, D. M.
Solov'ëva, I. G.
Pronkina, N. V.
Shishikova, I. V.
Kozlov, V. A.
Publication Title: 
Scandinavian Journal of Infectious Diseases

Few studies have focused on sepsis in patients with pre-existing immunosuppression. Since the numbers and the incidence of sepsis are increasing, sepsis in immunosuppressed patients will increase in importance. We studied the epidemiology of sepsis and risk factors for 28-d mortality in patients immunosuppressed prior to the onset of sepsis using data from the Academic Medical Center Consortium's (AMCC) prospective observational cohort study of sepsis. We compared characteristics of immunosuppressed (n =412) and immunocompetent (n =754) patients.

Poutsiaka, Debra D.
Davidson, Lisa E.
Kahn, Katherine L.
Bates, David W.
Snydman, David R.
Hibberd, Patricia L.
Subscribe to RSS - Immunocompromised Host